{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T22:40:04Z","timestamp":1735425604866,"version":"3.32.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-83085-0","type":"journal-article","created":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T08:42:03Z","timestamp":1735375323000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The mediating role of primary sclerosing cholangitis in the association between ulcerative colitis and hepatobiliary cancer investigated through Mendelian randomization"],"prefix":"10.1038","volume":"14","author":[{"given":"Fangming","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhui","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,28]]},"reference":[{"key":"83085_CR1","doi-asserted-by":"crossref","unstructured":"Yang, Y. et al. Emerging roles of long noncoding RNAs in cholangiocarcinoma: Advances and challenges. Cancer Commun. 40 (2020).","DOI":"10.1002\/cac2.12109"},{"key":"83085_CR2","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1111\/liv.15271","volume":"42","author":"KN van Munster","year":"2022","unstructured":"van Munster, K. N., Dijkgraaf, M. G. W., Elferink, O., Beuers, R. P. J., Ponsioen, C. Y. & U. & Symptom patterns in the daily life of PSC patients. Liver Int. 42, 1562\u20131570. https:\/\/doi.org\/10.1111\/liv.15271 (2022).","journal-title":"Liver Int."},{"key":"83085_CR3","doi-asserted-by":"publisher","unstructured":"Kasztelan-Szczerbinska, B., Rycyk-Bojarzynska, A., Szczerbinska, A. & Cichoz-Lach, H. Selected aspects of the intricate background of immune-related cholangiopathies: A critical overview. Nutrients  https:\/\/doi.org\/10.3390\/nu15030760 (2023).","DOI":"10.3390\/nu15030760"},{"key":"83085_CR4","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1136\/gutjnl-2020-322362","volume":"70","author":"PJ Trivedi","year":"2021","unstructured":"Trivedi, P. J. & Hirschfield, G. M. Recent advances in clinical practice: epidemiology of autoimmune liver diseases. Gut 70, 1989\u20132003. https:\/\/doi.org\/10.1136\/gutjnl-2020-322362 (2021).","journal-title":"Gut"},{"key":"83085_CR5","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/j.cgh.2019.07.011","volume":"17","author":"CL Bowlus","year":"2019","unstructured":"Bowlus, C. L., Lim, J. K. & Lindor, K. D. AGA clinical practice update on surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis: Expert review. Clin. Gastroenterol. Hepatol. 17, 2416\u20132422. https:\/\/doi.org\/10.1016\/j.cgh.2019.07.011 (2019).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"83085_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12072-020-10118-x","volume":"15","author":"M Prokopi","year":"2021","unstructured":"Prokopi, M. & Beuers, U. Management of primary sclerosing cholangitis and its complications: an algorithmic approach. Hep. Intl. 15, 6\u201320 (2021).","journal-title":"Hep. Intl."},{"key":"83085_CR7","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/ibd\/izz211","volume":"26","author":"M Van Der Have","year":"2020","unstructured":"Van Der Have, M. & Oldenburg, B. Is ulcerative colitis associated with primary sclerosing cholangitis an undertreated condition? Inflamm. Bowel Dis. 26, 780\u2013781. https:\/\/doi.org\/10.1093\/ibd\/izz211 (2020).","journal-title":"Inflamm. Bowel Dis."},{"key":"83085_CR8","doi-asserted-by":"crossref","unstructured":"Adamowicz, M., Stukan, I. & Milkiewicz, M. K. P. Agnieszka. Modulation of mismatch repair and the SOCS1\/p53 axis by microRNA-155 in the colon of patients with primary sclerosing cholangitis. Int. J. Mol. Sci. 23 (2022).","DOI":"10.3390\/ijms23094905"},{"key":"83085_CR9","doi-asserted-by":"publisher","unstructured":"Shah, S. C. et al. High risk of advanced colorectal neoplasia in patients with primary sclerosing cholangitis associated with inflammatory bowel disease. Clin. Gastroenterol. Hepatol. 16 https:\/\/doi.org\/10.1016\/j.cgh.2018.01.023 (2018).","DOI":"10.1016\/j.cgh.2018.01.023"},{"key":"83085_CR10","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1053\/j.gastro.2021.08.032","volume":"161","author":"B Barberio","year":"2021","unstructured":"Barberio, B. et al. Prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease: A systematic review and meta-analysis. Gastroenterology 161, 1865\u20131877. https:\/\/doi.org\/10.1053\/j.gastro.2021.08.032 (2021).","journal-title":"Gastroenterology"},{"key":"83085_CR11","doi-asserted-by":"crossref","unstructured":"Smith, G. D. & Ebrahim, S. \u2018Mendelian randomization\u2019: Can genetic epidemiology contribute to understanding environmental determinants of disease? Int. J. Epidemiol. 32 (2003).","DOI":"10.1093\/ije\/dyg070"},{"key":"83085_CR12","doi-asserted-by":"publisher","unstructured":"Richmond, R. C. & Davey Smith, G. Mendelian Randomization: Concepts and Scope. Cold Spring Harb Perspect. Med. https:\/\/doi.org\/10.1101\/cshperspect.a040501 (2022).","DOI":"10.1101\/cshperspect.a040501"},{"key":"83085_CR13","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova, V. W. et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: The STROBE-MR statement. JAMA 326, 1614\u20131621. https:\/\/doi.org\/10.1001\/jama.2021.18236 (2021).","journal-title":"JAMA"},{"key":"83085_CR14","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1186\/s12885-024-12453-w","volume":"24","author":"JX Xu","year":"2024","unstructured":"Xu, J. X., Zhu, Q. L., Bi, Y. M. & Peng, Y. C. New evidence: Metformin unsuitable as routine adjuvant for breast cancer: a drug-target mendelian randomization analysis. BMC Cancer 24, 691. https:\/\/doi.org\/10.1186\/s12885-024-12453-w (2024).","journal-title":"BMC Cancer"},{"key":"83085_CR15","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/ana.26464","volume":"92","author":"L Sun","year":"2022","unstructured":"Sun, L. et al. Association between human blood metabolome and the risk of Alzheimer\u2019s disease. Ann. Neurol. 92, 756\u2013767. https:\/\/doi.org\/10.1002\/ana.26464 (2022).","journal-title":"Ann. Neurol."},{"key":"83085_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-022-02251-1","volume":"20","author":"S Park","year":"2022","unstructured":"Park, S. et al. Nonlinear causal effects of estimated glomerular filtration rate on myocardial infarction risks: Mendelian randomization study. BMC Med. 20, 1\u201312 (2022).","journal-title":"BMC Med."},{"key":"83085_CR17","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41467-020-14389-8","volume":"11","author":"N Papadimitriou","year":"2020","unstructured":"Papadimitriou, N. et al. Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis. Nat. Commun. 11, 597. https:\/\/doi.org\/10.1038\/s41467-020-14389-8 (2020).","journal-title":"Nat. Commun."},{"key":"83085_CR18","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","volume":"35","author":"MA Kamat","year":"2019","unstructured":"Kamat, M. A. et al. PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinformatics 35, 4851\u20134853. https:\/\/doi.org\/10.1093\/bioinformatics\/btz469 (2019).","journal-title":"Bioinformatics"},{"key":"83085_CR19","doi-asserted-by":"publisher","first-page":"902142","DOI":"10.3389\/fendo.2022.902142","volume":"13","author":"L He","year":"2022","unstructured":"He, L. et al. Causal associations of obesity with achilles tendinopathy: A two-sample Mendelian randomization study. Front. Endocrinol. (Lausanne). 13, 902142. https:\/\/doi.org\/10.3389\/fendo.2022.902142 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"83085_CR20","doi-asserted-by":"publisher","unstructured":"Zhang, S. et al. Investigating causal relations between genetic-related intermediate endophenotype and risk of chronic prostatitis: Mendelian randomization study. Oxid. Med. Cell. Longev. 2022, 4560609. https:\/\/doi.org\/10.1155\/2022\/4560609 (2022).","DOI":"10.1155\/2022\/4560609"},{"key":"83085_CR21","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/ije\/dyx034","volume":"46","author":"OO Yavorska","year":"2017","unstructured":"Yavorska, O. O. & Burgess, S. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. Int. J. Epidemiol. 46, 1734\u20131739. https:\/\/doi.org\/10.1093\/ije\/dyx034 (2017).","journal-title":"Int. J. Epidemiol."},{"key":"83085_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-022-02578-9","volume":"20","author":"P Alipour","year":"2022","unstructured":"Alipour, P. et al. Investigation of the causal relationship between ALS and autoimmune disorders: a Mendelian randomization study. BMC Med. 20, 1\u20137 (2022).","journal-title":"BMC Med."},{"key":"83085_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13195-022-00963-3","volume":"14","author":"H Liu","year":"2022","unstructured":"Liu, H. et al. Mendelian randomization highlights significant difference and genetic heterogeneity in clinically diagnosed Alzheimer\u2019s disease GWAS and self-report proxy phenotype GWAX. Alzheimers Res. Ther. 14, 17 (2022).","journal-title":"Alzheimers Res. Ther."},{"key":"83085_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-024-03976-0","author":"JX Xu","year":"2024","unstructured":"Xu, J. X., Chen, Y. Y., Qi, L. N. & Peng, Y. C. Investigation of the causal relationship between breast cancer and thyroid cancer: a set of two-sample bidirectional Mendelian randomization study. Endocrine https:\/\/doi.org\/10.1007\/s12020-024-03976-0 (2024).","journal-title":"Endocrine"},{"key":"83085_CR25","doi-asserted-by":"publisher","unstructured":"Thompson, J. R., Minelli, C. & Del Greco, M. Mendelian randomization using public data from genetic consortia. Int. J. Biostat. https:\/\/doi.org\/10.1515\/ijb-2015-0074 (2016).","DOI":"10.1515\/ijb-2015-0074"},{"key":"83085_CR26","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1002\/sim.6522","volume":"34","author":"M Greco","year":"2015","unstructured":"Greco, M., Minelli, F. D., Sheehan, C., Thompson, J. R. & N. A. & Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome. Stat. Med. 34, 2926\u20132940. https:\/\/doi.org\/10.1002\/sim.6522 (2015).","journal-title":"Stat. Med."},{"key":"83085_CR27","doi-asserted-by":"publisher","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.3","volume":"4","author":"S Burgess","year":"2019","unstructured":"Burgess, S. et al. Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open. Res. 4, 186. https:\/\/doi.org\/10.12688\/wellcomeopenres.15555.3 (2019).","journal-title":"Wellcome Open. Res."},{"key":"83085_CR28","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1093\/aje\/kwy185","volume":"187","author":"J Bowden","year":"2018","unstructured":"Bowden, J., Hemani, G. & Davey Smith, G. Invited commentary: Detecting individual and global horizontal pleiotropy in Mendelian Randomization-A job for the humble heterogeneity statistic? Am. J. Epidemiol. 187, 2681\u20132685. https:\/\/doi.org\/10.1093\/aje\/kwy185 (2018).","journal-title":"Am. J. Epidemiol."},{"key":"83085_CR29","doi-asserted-by":"publisher","first-page":"10950","DOI":"10.1038\/s41598-023-35785-2","volume":"13","author":"J Zhao","year":"2023","unstructured":"Zhao, J., Li, K., Liao, X. & Zhao, Q. Causal associations between inflammatory bowel disease and primary biliary cholangitis: a two-sample bidirectional Mendelian randomization study. Sci. Rep. 13, 10950. https:\/\/doi.org\/10.1038\/s41598-023-35785-2 (2023).","journal-title":"Sci. Rep."},{"key":"83085_CR30","doi-asserted-by":"publisher","first-page":"13599","DOI":"10.1002\/cam4.6057","volume":"12","author":"J Huang","year":"2023","unstructured":"Huang, J. et al. Inflammatory bowel disease increases the risk of hepatobiliary pancreatic cancer: A two-sample Mendelian randomization analysis of European and East Asian populations. Cancer Med. 12, 13599\u201313609. https:\/\/doi.org\/10.1002\/cam4.6057 (2023).","journal-title":"Cancer Med."},{"key":"83085_CR31","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","volume":"391","author":"JK Dyson","year":"2018","unstructured":"Dyson, J. K., Beuers, U., Jones, D. E. J., Lohse, A. W. & Hudson, M. Primary sclerosing cholangitis. Lancet 391, 2547\u20132559. https:\/\/doi.org\/10.1016\/S0140-6736(18)30300-3 (2018).","journal-title":"Lancet"},{"key":"83085_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1136\/gut.52.2.165","volume":"52","author":"E Schrumpf","year":"2003","unstructured":"Schrumpf, E. & Boberg, K. M. Hepatic and extrahepatic malignancies and primary sclerosing cholangitis. Gut 52, 165 (2003).","journal-title":"Gut"},{"key":"83085_CR33","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S1665-2681(19)31880-0","volume":"7","author":"G V\u00e1zquez-Elizondo","year":"2008","unstructured":"V\u00e1zquez-Elizondo, G., Muci\u00f1o-Bermejo, J. & M\u00e9ndez-S\u00e1nchez, N. Gallbladder disease in patients with primary sclerosing cholangitis. Ann. Hepatol. 7, 182\u2013183 (2008).","journal-title":"Ann. Hepatol."},{"key":"83085_CR34","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1111\/j.1572-0241.2002.05677.x","volume":"97","author":"DC Buckles","year":"2002","unstructured":"Buckles, D. C., Lindor, K. D., Larusso, N. F., Petrovic, L. M. & Gores, G. J. In primary sclerosing cholangitis, gallbladder polyps are frequently malignant. Am. J. Gastroenterol. 97, 1138\u20131142 (2002).","journal-title":"Am. J. Gastroenterol."},{"key":"83085_CR35","doi-asserted-by":"publisher","unstructured":"Castro, F. A. et al. Increased risk of hepatobiliary cancers after hospitalization for autoimmune disease. Clin. Gastroenterol. Hepatol. https:\/\/doi.org\/10.1016\/j.cgh.2013.11.007 (2014).","DOI":"10.1016\/j.cgh.2013.11.007"},{"key":"83085_CR36","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1158\/1055-9965.EPI-20-1241","volume":"30","author":"R Erichsen","year":"2021","unstructured":"Erichsen, R. et al. Hepatobiliary cancer risk in patients with inflammatory bowel disease: A Scandinavian population-based cohort study. Cancer Epidemiol. Biomark. Prev. 30, 886\u2013894. https:\/\/doi.org\/10.1158\/1055-9965.EPI-20-1241 (2021).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"83085_CR37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/hep.24351","volume":"54","author":"GL Tyson","year":"2011","unstructured":"Tyson, G. L. & El-Serag, H. B. Risk factors for cholangiocarcinoma. Hepatology (Baltimore Md) 54, 173\u2013184. https:\/\/doi.org\/10.1002\/hep.24351 (2011).","journal-title":"Hepatol. (Baltimore Md)"},{"key":"83085_CR38","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1053\/j.gastro.2020.05.049","volume":"159","author":"PJ Trivedi","year":"2020","unstructured":"Trivedi, P. J. et al. Effects of primary sclerosing cholangitis on risks of cancer and death in people with inflammatory bowel disease, based on sex, race, and age. Gastroenterology 159, 915\u2013928. https:\/\/doi.org\/10.1053\/j.gastro.2020.05.049 (2020).","journal-title":"Gastroenterology"},{"key":"83085_CR39","doi-asserted-by":"publisher","first-page":"840935","DOI":"10.3389\/fimmu.2022.840935","volume":"13","author":"M de Krijger","year":"2022","unstructured":"de Krijger, M. et al. Epigenetic signatures discriminate patients with primary sclerosing cholangitis and ulcerative colitis from patients with ulcerative colitis. Front. Immunol. 13, 840935. https:\/\/doi.org\/10.3389\/fimmu.2022.840935 (2022).","journal-title":"Front. Immunol."},{"key":"83085_CR40","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.3748\/wjg.v21.i6.1956","volume":"21","author":"AB de Vries","year":"2015","unstructured":"de Vries, A. B., Janse, M., Blokzijl, H. & Weersma, R. K. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. World J. Gastroenterol. 21, 1956\u20131971. https:\/\/doi.org\/10.3748\/wjg.v21.i6.1956 (2015).","journal-title":"World J. Gastroenterol."},{"key":"83085_CR41","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5009\/gnl16510","volume":"12","author":"C Palmela","year":"2018","unstructured":"Palmela, C., Peerani, F., Castaneda, D., Torres, J. & Itzkowitz, S. H. Inflammatory bowel disease and primary sclerosing cholangitis: A review of the phenotype and associated specific features. Gut Liver 12, 17\u201329. https:\/\/doi.org\/10.5009\/gnl16510 (2018).","journal-title":"Gut Liver"},{"key":"83085_CR42","doi-asserted-by":"publisher","first-page":"531","DOI":"10.14218\/JCTH.2021.00344","volume":"10","author":"T Da Cunha","year":"2022","unstructured":"Da Cunha, T., Vaziri, H. & Wu, G. Y. Primary sclerosing cholangitis and inflammatory bowel disease: A review. J. Clin. Transl Hepatol. 10, 531\u2013542. https:\/\/doi.org\/10.14218\/JCTH.2021.00344 (2022).","journal-title":"J. Clin. Transl Hepatol."},{"key":"83085_CR43","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1053\/j.gastro.2013.06.052","volume":"145","author":"JE Eaton","year":"2013","unstructured":"Eaton, J. E., Talwalkar, J. A., Lazaridis, K. N., Gores, G. J. & Lindor, K. D. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology 145, 521\u2013536. https:\/\/doi.org\/10.1053\/j.gastro.2013.06.052 (2013).","journal-title":"Gastroenterology"},{"key":"83085_CR44","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1067\/mge.2002.125367","volume":"56","author":"RM Soetikno","year":"2002","unstructured":"Soetikno, R. M., Lin, O. S., Heidenreich, P. A., Young, H. S. & Blackstone, M. O. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest. Endosc. 56, 48\u201354 (2002).","journal-title":"Gastrointest. Endosc"},{"key":"83085_CR45","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/00365521.2017.1421705","volume":"53","author":"L Lindstr\u00f6m","year":"2018","unstructured":"Lindstr\u00f6m, L. et al. Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study. Scand. J. Gastroenterol. 53, 297\u2013304. https:\/\/doi.org\/10.1080\/00365521.2017.1421705 (2018).","journal-title":"Scand. J. Gastroenterol."},{"key":"83085_CR46","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","volume":"15","author":"A Tripathi","year":"2018","unstructured":"Tripathi, A. et al. The gut-liver axis and the intersection with the microbiome. Nat. Rev. Gastroenterol. Hepatol. 15, 397\u2013411. https:\/\/doi.org\/10.1038\/s41575-018-0011-z (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"83085_CR47","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41564-018-0333-1","volume":"4","author":"N Nakamoto","year":"2019","unstructured":"Nakamoto, N. et al. Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis. Nat. Microbiol. 4, 492\u2013503. https:\/\/doi.org\/10.1038\/s41564-018-0333-1 (2019).","journal-title":"Nat. Microbiol."},{"key":"83085_CR48","doi-asserted-by":"publisher","unstructured":"\u00d6zdirik, B., M\u00fcller, T., Wree, A., Tacke, F. & Sigal, M. The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary Malignancies. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms22136975 (2021).","DOI":"10.3390\/ijms22136975"},{"key":"83085_CR49","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1113\/jphysiol.2011.219691","volume":"590","author":"E Seki","year":"2012","unstructured":"Seki, E. & Schnabl, B. Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut. J. Physiol. 590, 447\u2013458. https:\/\/doi.org\/10.1113\/jphysiol.2011.219691 (2012).","journal-title":"J. Physiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83085-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83085-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83085-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T22:06:26Z","timestamp":1735423586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83085-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,28]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["83085"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-83085-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,28]]},"assertion":[{"value":"28 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31433"}}